Sirtuin-dependent metabolic and epigenetic regulation of macrophages during tuberculosis

Kangling Zhang1, Mark L Sowers1, Ellie I Cherryhomes1

  • 1Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States.

Insights

Macrophages utilize glucose metabolism to fight infections like tuberculosis. Sirtuins, key enzymes, link this metabolism to epigenetic regulation, offering new therapeutic targets for enhancing macrophage antimicrobial functions.

Area of Science:

  • Immunology
  • Cell Biology
  • Metabolic pathways

Background:

  • Macrophages are crucial phagocytic cells that combat infections, including tuberculosis caused by Mycobacterium tuberculosis (MTB).
  • MTB infects and persists within macrophages, necessitating robust antimicrobial mechanisms.
  • Macrophages employ reactive oxygen/nitrogen species (ROS/RNS) and autophagy to eliminate intracellular pathogens.

Purpose of the Study:

  • To elucidate the role of glucose metabolism in regulating macrophage antimicrobial functions.
  • To describe the function of sirtuins in the epigenetic regulation of macrophage activation.
  • To illustrate the interplay between immunometabolism and epigenetics in controlling macrophage responses.

Main Methods:

  • Review of literature on macrophage function, glucose metabolism, and epigenetic regulation.
  • Analysis of the role of sirtuins (NAD+-dependent deacetylases) in cellular processes.
  • Examination of the cross-talk between metabolic pathways and epigenetic modifications.

Main Results:

  • Glucose metabolism is essential for macrophage growth and generates key mediators for epigenetic regulation.
  • Sirtuins epigenetically regulate autophagy, ROS/RNS production, and levels of acetyl-CoA, NAD+, and S-adenosine methionine (SAM).
  • A significant cross-talk exists between immunometabolism and epigenetics, influencing macrophage activation and antimicrobial capacity.

Conclusions:

  • Sirtuins play a pivotal role in linking immunometabolism and epigenetics to control macrophage antimicrobial functions.
  • Targeting sirtuins offers a promising therapeutic strategy to modulate macrophage immunometabolism and enhance their ability to fight infections.
  • Understanding this metabolic-epigenetic interplay is key to developing novel treatments for infectious diseases like tuberculosis.